1. Introduction The metabolic syndrome (MetS) is a cluster of abnormalities including abdominal obesity, glucose intolerance, hypertension, and dyslipidae mia, factors that are all associated with an increased cardiovascular (CV) risk [1]
Montalto, G., Rizzo, M., Mikhailidis, D.P. (2014). Managing the Cardiovascular Risk Associated with the Metabolic Syndrome. CURRENT PHARMACEUTICAL DESIGN, 31(20), 4941-4943 [10.2174/1381612819666131206112537].
Managing the Cardiovascular Risk Associated with the Metabolic Syndrome
MONTALTO, Giuseppe
;RIZZO, Manfredi;
2014-01-01
Abstract
1. Introduction The metabolic syndrome (MetS) is a cluster of abnormalities including abdominal obesity, glucose intolerance, hypertension, and dyslipidae mia, factors that are all associated with an increased cardiovascular (CV) risk [1]
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
CPD editoriale 2014.pdf
Solo gestori archvio
Descrizione: Articolo principale
Tipologia:
Versione Editoriale
Dimensione
46.43 kB
Formato
Adobe PDF
|
46.43 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
